CpG and LPS can interfere negatively with prion clearance in macrophage and microglial cells

FEBS Journal

Volumn 274, Issue 22, 2007, Pages 5834-5844

  Gilch, Sabine ^a   Schmitz, Frank ^a   Aguib, Yasmine ^a   Kehler, Claudia ^a   Bülow, Sigrid ^a   Bauer, Stefan ^b   Kremmer, Elisabeth ^c   Schätzl, Hermann M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Innate immunity; PAMP; Prion; Prion clearance; Toll like receptor

Indexed keywords

CELL PROTEIN; CYTOSINE; GUANOSINE; LIPOPOLYSACCHARIDE; PHOSPHATE; PRION PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; UPREGULATION;

ANIMALS; CPG ISLANDS; FLOW CYTOMETRY; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED STRAINS; MICROGLIA; PRIONS;

EID: 35748956812     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.06105.x     Document Type: Article

References (60)

1. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95, 13 363 13 383.
2. Aguzzi A Polymenidou M (2004) Mammalian prion biology: one century of evolving concepts. Cell 116, 313 327.
3. Beekes M McBride PA (2007) The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies. FEBS J 274, 588 605.
4. Tatzelt J Schätzl HM (2007) Molecular basis of cerebral neurodegeneration in prion diseases. FEBS J 274, 606 611.
5. Nunziante M, Gilch S Schätzl HM (2003) Prion diseases: from molecular biology to intervention strategies. Chembiochem 4, 1268 1284.
6. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339 1347.
7. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R Wuthrich K (1996) NMR structure of the mouse prion protein domain PrP (121-321). Nature 382, 180 182.
8. Prusiner SB, Scott M, Foster D, Pan KM, Groth D, Mirenda C, Torchia M, Yang SL, Serban D, Carlson GA, et al. (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673 686.
9. Come JH, Fraser PE Lansbury PT Jr. (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 90, 5959 5963.
10. Borchelt DR, Scott M, Taraboulos A, Stahl N Prusiner SB (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 110, 743 752.
11. Caughey B Raymond GJ (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase- sensitive. J Biol Chem 266, 18 217 18 223.
12. Zhang Y, Spiess E, Groschup MH Bürkle A (2003) Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells. J Gen Virol 84, 2279 2283.
13. Legname G, Baskakov IV, Nguyen HOB, Riesner D, Cohen FE, DeArmond SJ Prusiner SB (2004) Synthetic mammalian prions. Science 305, 673 676.
14. Castilla J, Saa P, Hetz C Soto C (2005) In vitro generation of infectious scrapie prions. Cell 121, 195 206.
15. Oldstone MB, Race R, Thomas D, Lewicki H, Homann D, Smelt S, Holz A, Koni P, Lo D, Chesebro B Flavell R (2002) Lymphotoxin-alpha- and lymphotoxin-beta-deficient mice differ in susceptibility to scrapie: evidence against dendritic cell involvement in neuroinvasion. J Virol 76, 4357 4363.
16. Klein MA, Frigg R, Raeber AJ, Flechsig E, Hegyi I, Zinkernagel RM, Weissmann C Aguzzi A (1998) PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat Med 4, 1429 1433.
17. Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann H, Bootz F, Suter M, Zinkernagel RM Aguzzi A (1997) A crucial role for B cells in neuroinvasive scrapie. Nature 390, 687 690.
18. Mabbott NA, Bruce ME, Botto M, Walport MJ Pepys MB (2001) Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med 7, 485 487.
19. Heppner FL, Christ AD, Klein MA, Prinz M, Fried M, Kraehenbuhl JP Aguzzi A (2001) Transepithelial prion transport by M cells. Nat Med 7, 976 977.
20. Prinz M, Montrasio F, Klein MA, Schwarz P, Priller J, Odermatt B, Pfeffer K Aguzzi A (2002) Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc Natl Acad Sci USA 99, 919 924.
21. Huang FP, Farquhar CF, Mabbott NA, Bruce ME MacPherson GG (2002) Migrating intestinal dendritic cells transport PrP(Sc) from the gut. J Gen Virol 83, 267 271.
22. Mabbott NA, Young J, McConnell I Bruce ME (2003) Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. J Virol 77, 6845 6854.
23. Luhr KM, Wallin RP, Ljunggren HG, Low P, Taraboulos A Kristensson K (2002) Processing and degradation of exogenous prion protein by CD11c(+) myeloid dendritic cells in vitro. J Virol 76, 12 259 12 264.
24. Luhr KM, Nordstrom EK, Low P, Ljunggren HG, Taraboulos A Kristensson K (2004) Cathepsin B and L are involved in degradation of prions in GT1-1 neuronal cells. J Virol 78, 4776 4782.
25. Rybner-Barnier C, Jacquemot C, Cuche C, Dore G, Majlessi L, Gabellec MM, Moris A, Schwartz O, Di Santo J, Cumano A, et al. (2006) Processing of the bovine spongiform encephalopathy-specific prion protein by dendritic cells. J Virol 80, 4656 4663.
26. Mohan J, Hopkins J Mabbott NA (2005) Skin-derived dendritic cells acquire and degrade the scrapie agent following in vitro exposure. Immunology 116, 122 133.
27. Aucouturier P, Geissmann F, Damotte D, Saborio GP, Meeker HC, Kascsak R, Kascsak R, Carp RI Wisniewski T (2001) Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J Clin Invest 108, 703 708.
28. Beringue V, Demoy M, Lasmezas CI, Gouritin B, Weingarten C, Deslys JP, Andreux JP, Couvreur P Dormont D (2000) Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis. J Pathol 190, 495 502.
29. Maignien T, Shakwed M, Calvo P, Marce D, Sales N, Fattal E, Deslys JP, Couvreur P Lasmezas CI (2005) Role of gut macrophages in mice orally contaminated with scrapie or BSE. Int J Pharmaceut 298, 293 304.
30. Carp RI Callahan SM (1981) In vitro interaction of scrapie agent and mouse peritoneal macrophages. Intervirology 16, 8 13.
31. Carp RI Callahan SM (1982) Effect of mouse peritoneal macrophages on scrapie infectivity during extended in vitro incubation. Intervirology 17, 201 207.
32. Burwinkel M, Riemer C, Schwarz A, Schultz J, Neidhold S, Bamme T Baier M (2004) Role of cytokines and chemokines in prion infections of the central nervous system. Int J Dev Neurosci 22, 497 505.
33. Baker CA, Lu ZY, Zaitsev I Manuelidis L (1999) Microglial activation varies in different models of Creutzfeldt-Jakob disease. J Virol 73, 5089 5097.
34. Giese A, Brown DR, Groschup MH, Feldmann C, Haist I Kretzschmar HA (1998) Role of microglia in neuronal cell death in prion disease. Brain Pathol 8, 449 457.
35. Baker CA, Martin D Manuelidis L (2002) Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J Virol 76, 10 905 10 913.
36. Iwamaru Y, Takenouchi T, Ogihara K, Hoshino M, Takata M, Imamura M, Tagawa Y, Hayashi-Kato H, Ushiki-Kaku Y, Shimizu Y, et al. (2007) Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains. J Virol 81, 1524 1527.
37. Durig J, Giese A, Schulz-Schaeffer W, Rosenthal C, Schmucker U, Bieschke J, Duhrsen U Kretzschmar HA (2000) Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytes. Br J Haematol 108, 488 495.
38. Bainbridge J Walker KB (2005) The normal cellular form of prion protein modulates T cell responses. Immunol Lett 96, 147 150.
39. Martinez del Hoyo G, Lopez-Bravo M, Metharom P, Ardavin C Aucouturier P (2006) Prion protein expression by mouse dendritic cells is restricted to the nonplasmacytoid subsets and correlates with the maturation state. J Immunol 177, 6137 6142.
40. Ballerini C, Gourdain P, Bachy V, Blanchard N, Levavasseur E, Gregoire S, Fontes P, Aucouturier P, Hivroz C Carnaud C (2006) Functional implication of cellular prion protein in antigen-driven interactions between T cells and dendritic cells. J Immunol 176, 7254 7262.
41. Lotscher M, Recher M, Hunziker L Klein MA (2003) Immunologically induced, complement-dependent up-regulation of the prion protein in the mouse spleen: follicular dendritic cells versus capsule and trabeculae. J Immunol 170, 6040 6047.
42. Krebs B, Dorner-Ciossek C, Schmalzbauer R, Vassallo N, Herms J Kretzschmar HA (2006) Prion protein induced signaling cascades in monocytes. Biochem Biophys Res Commun 340, 13 22.
43. de Almeida CJ, Chiarini LB, da Silva JPE, Silva PM, Martins MA Linden R (2005) The cellular prion protein modulates phagocytosis and inflammatory response. J Leukoc Biol 77, 238 246.
44. Schatzl HM, Laszlo L, Holtzman DM, Tatzelt J, DeArmond SJ, Weiner RI, Mobley WC Prusiner SB (1997) A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol 71, 8821 8831.
45. Gilch S, Winklhofer KF, Groschup MH, Nunziante M, Lucassen R, Spielhaupter C, Muranyi W, Riesner D, Tatzelt J Schatzl HM (2001) Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease. EMBO J 20, 3957 3966.
46. Gilch S, Nunziante M, Ertmer A, Wopfner F, Laszlo L Schatzl HM (2004) Recognition of lumenal prion protein aggregates by post-ER quality control mechanisms is mediated by the preoctarepeat region of PrP. Traffic 5, 300 313.
47. Schwarzbaum S Diamond B (1983) The J744.2 cell line presents antigen in an I region restricted manner. J Immunol 131, 674 677.
48. Blasi E, Barluzzi R, Bocchini V, Mazzolla R Bistoni F (1990) Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 27, 229 237.
49. Huang FP MacPherson GG (2004) Dendritic cells and oral transmission of prion diseases. Adv Drug Deliv Rev 56, 901 913.
50. O'Neill LAJ (2002) Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol 23, 296 300.
51. Sethi S, Lipford G, Wagner H Kretzschmar H (2002) Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet 360, 229 230.
52. Heikenwalder M, Polymenidou M, Junt T, Sigurdson C, Wagner H, Akira S, Zinkernagel R Aguzzi A (2004) Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 10, 187 192.
53. Wykes M, Pombo A, Jenkins C MacPherson GG (1998) Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol 161, 1313 1319.
54. Vorberg I, Raines A Priola SA (2004) Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro. J Biol Chem 279, 29 218 29 225.
55. Dickinson AG, Fraser H, McConnell I Outram GW (1978) Mitogenic stimulation of the host enhances susceptibility to scrapie. Nature 272, 54 55.
56. Heikenwalder M, Zeller N, Seeger H, Prinz M, Klohn PC, Schwarz P, Ruddle NH, Weissman C Aguzzi A (2005) Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307, 1107 1110.
57. Seeger H, Heikenwalder M, Zeller N, Kranich J, Schwarz P, Gaspert A, Seifert B, Miele G Aguzzi A (2005) Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 310, 324 326.
58. Sc in mammary glands of sheep affected by scrapie and mastitis. Nat Med 11, 1137 1138.
59. Ertmer A, Gilch S, Yun SW, Flechsig E, Klebl B, Stein-Gerlach M, Klein MA Schatzl HM (2004) The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells. J Biol Chem 279, 41 918 41 927.
60. Schmitz F, Heit A, Guggemoos S, Krug A, Mages J, Schiemann M, Adler H, Drexler I, Haas T, Lang R Wagner H (2007) Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur J Immunol 37, 315 327.